PAPADOPOULOS STELIOS - Insider Non-Derivative Transactions at Regulus Therapeutics Inc. (RGLS) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Mar 14, 2024, PAPADOPOULOS STELIOS's relationship to Regulus Therapeutics Inc. (RGLS) is Director, and currently has 978,388 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other RGLS insiders.

Data Source: SEC.
PAPADOPOULOS STELIOS - Insider Non-Derivative Transactions of RGLS Common Stock
PAPADOPOULOS STELIOS - Insider Non-Derivative Transactions at RGLS
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Mar 15, 2024 Acquisition -- (Common Stock) 250000 1.6 978388
Apr 14, 2023 Acquisition -- (Common Stock) 222198 0.9 728388